Fennebresque Kim S has filed to sell 4,929 shares of BlueLinx Holdings Inc. The shares are valued at approximately $367,161, highlighting a significant transaction in the company's stock. This move may indicate a shift in the company's leadership dynamics, as Fennebresque serves as a director at BlueLinx.

Background

Fennebresque Kim S is associated with BlueLinx Holdings Inc., a company listed under the SEC with a Central Index Key of 0001301787. BlueLinx operates within the wholesale lumber, plywood, millwork, and wood panels industry. The company is incorporated in Delaware and has its business address at 1950 Spectrum Circle, Suite 300, Marietta, GA.

What the Filing Says

According to the recent filing, Fennebresque plans to sell 4,929 shares of BlueLinx Holdings, which were acquired through restricted stock units granted on May 19, 2022, and May 19, 2023. The filing states, "The approximate sale date is 11/05/2026," indicating a clear timeline for this transaction.

Impact

This transaction could affect various stakeholders within BlueLinx, including investors and employees. As a director, Fennebresque's decision to sell shares may influence market perceptions and investor confidence in the company's leadership.

What's Next

The filing does not say what happens next.

Recent Activity

In addition to the upcoming sale of shares, Fennebresque Kim S has also sold 34,138 shares of BlueLinx in a separate transaction on August 6, 2026, which generated gross proceeds of approximately $2,872,712. This suggests a pattern of selling activity that may be of interest to investors monitoring the company's leadership actions.

Shareholder Context

The total number of outstanding shares for BlueLinx Holdings Inc. is reported to be 7,864,549. This context is important as it highlights the proportion of shares being sold by Fennebresque in relation to the overall company share structure.

Brokerage Information

The shares will be sold through Charles Schwab & Co., Inc., which is noted as the broker handling the transaction. This detail may provide insights into the trading mechanisms involved in the sale.

Filing Specifics

The filing is categorized under Form 144, which is used for the sale of restricted and control securities, and is governed by the Securities Act of 1933. This regulatory framework is designed to provide transparency in the sale of securities by insiders.

Missing Information

The filing does not include any information regarding Fennebresque's future plans with respect to his remaining shares or any potential impact on BlueLinx's strategic direction following this transaction.